Evidence map›Paper›PMID 37175011›Full record

ReviewDiagnostics (Basel, Switzerland)2023

Optical Coherence Tomography Angiography in Retinal Vascular Disorders.

Charles Jit Teng Ong, Mark Yu Zheng Wong, Kai Xiong Cheong, Jinzhi Zhao, Kelvin Yi Chong Teo, Tien-En Tan

Open access · goldAbstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Faricimab: current evidence for the treatment of retinal vein occlusion.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Review
  10. Article
  11. Article
  12. Retinal Artery Occlusion: A Review of Current Management Practices.Journal of ophthalmic & vision research · 2024
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Charles Jit Teng OngSingapore Eye Research Institute, Singapore National Eye Centre, Singapore 168751, Singapore.
Mark Yu Zheng WongSingapore Eye Research Institute, Singapore National Eye Centre, Singapore 168751, Singapore.
Kai Xiong CheongSingapore Eye Research Institute, Singapore National Eye Centre, Singapore 168751, Singapore.
Jinzhi ZhaoSingapore Eye Research Institute, Singapore National Eye Centre, Singapore 168751, Singapore.
Kelvin Yi Chong TeoSingapore Eye Research Institute, Singapore National Eye Centre, Singapore 168751, Singapore.
Tien-En TanSingapore Eye Research Institute, Singapore National Eye Centre, Singapore 168751, Singapore.ORCID 0000-0002-9869-5159
Singapore National Eye Center · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditionally, abnormalities of the retinal vasculature and perfusion in retinal vascular disorders, such as diabetic retinopathy and retinal vascular occlusions, have been visualized with dye-based fluorescein angiography (FA). Optical coherence tomography angiography (OCTA) is a newer, alternative modality for imaging the retinal vasculature, which has some advantages over FA, such as its dye-free, non-invasive nature, and depth resolution. The depth resolution of OCTA allows for characterization of the retinal microvasculature in distinct anatomic layers, and commercial OCTA platforms also provide automated quantitative vascular and perfusion metrics. Quantitative and qualitative OCTA analysis in various retinal vascular disorders has facilitated the detection of pre-clinical vascular changes, greater understanding of known clinical signs, and the development of imaging biomarkers to prognosticate and guide treatment. With further technological improvements, such as a greater field of view and better image quality processing algorithms, it is likely that OCTA will play an integral role in the study and management of retinal vascular disorders. Artificial intelligence methods-in particular, deep learning-show promise in refining the insights to be gained from the use of OCTA in retinal vascular disorders. This review aims to summarize the current literature on this imaging modality in relation to common retinal vascular disorders.

Indexed as

artificial intelligencediabetic retinopathyimaging modalitynarrative reviewoptical coherence tomography angiographyretinal artery occlusionretinal vascular diseasesretinal vein occlusion

Identifiers

PMID37175011
PMCPMC10178415
OpenAlexW4376630773

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.